Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.

IF 3.5 3区 医学 Q1 SURGERY
BJS Open Pub Date : 2024-05-08 DOI:10.1093/bjsopen/zrae053
Emelie Nilsson, Erik Wetterholm, Ingvar Syk, Henrik Thorlacius, Carl-Fredrik Rönnow
{"title":"Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.","authors":"Emelie Nilsson, Erik Wetterholm, Ingvar Syk, Henrik Thorlacius, Carl-Fredrik Rönnow","doi":"10.1093/bjsopen/zrae053","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endoscopic resection of T1 colon cancer (CC) is currently limited by guidelines related to risk of lymph node metastases. However, clinical outcome following endoscopic and surgical resection is poorly investigated.</p><p><strong>Method: </strong>A retrospective multicentre national cohort study was conducted on prospectively collected data from the Swedish colorectal cancer registry on all non-pedunculated T1 CC patients undergoing surgical and endoscopic resection between 2009 and 2021. Patients were categorized on the basis of deep submucosal invasion (Sm2-3), lymphovascular invasion (LVI), poor tumour differentiation, and R1/Rx into low- and high-risk cases. The primary outcomes of interest were recurrence rates and disease-free interval (DFI, defined as time from treatment to date of recurrence) according to resection methods and risk factors (sex, age at diagnosis, histologic grade, LVI, perineural invasion, mucinous subtype, submucosal invasion, tumour location, resection margin and nodal positivity in the surgical group).</p><p><strong>Results: </strong>In total, 1805 patients undergoing endoscopic (488) and surgical (1317) resection with 60.0 months median follow-up were included. Recurrence occurred in 18 (3.7%) endoscopically and 48 (3.6%) surgically resected patients. Adjuvant treatment was administered in 7.4% and 0.2% of the cases respectively in the surgical and endoscopically treated patients. Five-year DFI was 95.6% after endoscopic and 96.2% after surgical resection, with no significant difference when adjusting for confounding factors (HR 1.03, 95% c.i. 0.56 to 1.91, P = 0.920). There were no statistically significant differences in recurrence comparing endoscopic (1.7%) versus surgical (3.6%) low-risk and endoscopic (5.4%) versus surgical (3.8%) high-risk cases. LVI was the only significant risk factor for recurrence in multivariate Cox regression (HR 3.73, 95% c.i. 1.76 to 7.92, P < 0.001).</p><p><strong>Conclusions: </strong>This study shows no difference in recurrence after endoscopic and surgical resection in high-risk T1 CC. Although it was not possible to match groups according to treatment, the multivariate analysis showed that lymphovascular invasion was the only independent risk factor for recurrence.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170496/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJS Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/bjsopen/zrae053","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Endoscopic resection of T1 colon cancer (CC) is currently limited by guidelines related to risk of lymph node metastases. However, clinical outcome following endoscopic and surgical resection is poorly investigated.

Method: A retrospective multicentre national cohort study was conducted on prospectively collected data from the Swedish colorectal cancer registry on all non-pedunculated T1 CC patients undergoing surgical and endoscopic resection between 2009 and 2021. Patients were categorized on the basis of deep submucosal invasion (Sm2-3), lymphovascular invasion (LVI), poor tumour differentiation, and R1/Rx into low- and high-risk cases. The primary outcomes of interest were recurrence rates and disease-free interval (DFI, defined as time from treatment to date of recurrence) according to resection methods and risk factors (sex, age at diagnosis, histologic grade, LVI, perineural invasion, mucinous subtype, submucosal invasion, tumour location, resection margin and nodal positivity in the surgical group).

Results: In total, 1805 patients undergoing endoscopic (488) and surgical (1317) resection with 60.0 months median follow-up were included. Recurrence occurred in 18 (3.7%) endoscopically and 48 (3.6%) surgically resected patients. Adjuvant treatment was administered in 7.4% and 0.2% of the cases respectively in the surgical and endoscopically treated patients. Five-year DFI was 95.6% after endoscopic and 96.2% after surgical resection, with no significant difference when adjusting for confounding factors (HR 1.03, 95% c.i. 0.56 to 1.91, P = 0.920). There were no statistically significant differences in recurrence comparing endoscopic (1.7%) versus surgical (3.6%) low-risk and endoscopic (5.4%) versus surgical (3.8%) high-risk cases. LVI was the only significant risk factor for recurrence in multivariate Cox regression (HR 3.73, 95% c.i. 1.76 to 7.92, P < 0.001).

Conclusions: This study shows no difference in recurrence after endoscopic and surgical resection in high-risk T1 CC. Although it was not possible to match groups according to treatment, the multivariate analysis showed that lymphovascular invasion was the only independent risk factor for recurrence.

内镜和手术切除后高风险 T1 结肠癌的复发风险:基于登记的队列研究。
背景:目前,T1 结肠癌(CC)的内镜切除术受到与淋巴结转移风险相关的指南的限制。然而,对内镜和手术切除后的临床疗效研究甚少:瑞典结直肠癌登记处前瞻性地收集了2009年至2021年间所有接受手术和内镜切除的非截石位T1 CC患者的数据,并以此为基础开展了一项回顾性多中心全国队列研究。根据粘膜下深层侵犯(Sm2-3)、淋巴管侵犯(LVI)、肿瘤分化差和R1/Rx将患者分为低危和高危病例。根据切除方法和风险因素(手术组的性别、诊断时的年龄、组织学分级、LVI、神经周围侵犯、粘液亚型、粘膜下侵犯、肿瘤位置、切除边缘和结节阳性),主要研究结果为复发率和无病间隔期(DFI,定义为从治疗到复发日期的时间):共有 1805 名患者接受了内镜(488 例)和手术(1317 例)切除,中位随访时间为 60.0 个月。18例(3.7%)内镜切除患者和48例(3.6%)手术切除患者复发。手术和内镜治疗患者中分别有7.4%和0.2%的病例接受了辅助治疗。内镜和手术切除后的五年DFI分别为95.6%和96.2%,调整混杂因素后无显著差异(HR 1.03,95% c.i.0.56至1.91,P = 0.920)。内镜(1.7%)与手术(3.6%)低风险病例和内镜(5.4%)与手术(3.8%)高风险病例相比,复发率无明显统计学差异。在多变量考克斯回归中,LVI是复发的唯一重要风险因素(HR 3.73,95% c.i.1.76至7.92,P <0.001):本研究表明,高危T1 CC患者在内镜和手术切除后的复发率没有差异。虽然无法根据治疗方法进行分组,但多变量分析表明,淋巴管侵犯是复发的唯一独立风险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BJS Open
BJS Open SURGERY-
CiteScore
6.00
自引率
3.20%
发文量
144
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信